MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurophysiology"

  • 2022 International Congress

    Towards a Machine Learning Based Classification System for Hyperkinetic Movement Disorders: Generating a Neurophysiological Feature Set

    E. V.D. Brandhof, S. V.D. Veen, G. Russo, I. Tuitert, J. Dalenberg, M. V.D. Stouwe, J. Elting, M. Biehl, M. de Koning-Tijssen (Groningen, Netherlands)

    Objective: Generating a set of significant neurophysiological features to build a machine learning based diagnostic system for hyperkinetic movement disorders. Background: Hyperkinetic movement disorders cause…
  • 2022 International Congress

    Determination of metabotropic glutamate receptor 2/3 distribution with [3H]-LY-341,495 in Parkinson’s disease patients with visual hallucinations

    D. Bedard, E. Kim, I. Frouni, P. Huot (Montreal, Canada)

    Objective: To determine the distribution and levels of metabotropic glutamate 2/3 (mGlu2/3) receptors in brain tissue from patients with Parkinson’s disease (PD) with visual hallucinations (VHs).…
  • 2022 International Congress

    Longitudinal study of clinical and neurophysiological features of essential tremor

    L. Angelini, A. de Biase, G. Paparella, A. Di Vita, M. Panfili, A. Maraone, R. Margiotta, A. Berardelli, M. Bologna (Rome, Italy)

    Objective: This study investigates how motor and non-motor manifestations of essential tremor (ET) progress over time. Background: ET is a common and heterogeneous movement disorder…
  • 2022 International Congress

    Evoked resonant neural activity within the dorsolateral subthalamic nucleus as a biomarker for the targeting of deep brain stimulation for Parkinson’s disease

    H. Simpson, S. Xu, W. Lee, A. Begg, K. Bulluss, H. Mcdermott, W. Thevathasan, T. Perera (Melbourne, Australia)

    Objective: The objective of the study was to determine the anatomical localisation of evoked resonant neural activity (ERNA), which is being investigated as a potential…
  • 2022 International Congress

    Gait declines faster over time in people with Parkinson’s disease converting to a freezing of gait phenotype

    T. Virmani, A. Glover, L. Pillai (Little Rock, USA)

    Objective: To monitor gait progression in people with Parkinson’s disease (PwPD) who convert from a non-freezing (noFOG) to a freezing of gait (FOG) phenotype. Background:…
  • 2022 International Congress

    Modulation of the mesencephalic locomotor region activity during gait in parkinson’s disease patients

    Y. Mullie, J. Bourilhon, C. Olivier, A. Collomb-Clerc, K. Lehongre, N. Georges, C. Karachi, M. Welter (Paris, France)

    Objective: Deciphering the role of the MLR in gait and balance disorders in PD patients Background: Lesion or dysfunction of the MLR, including the Pedunculopontine…
  • 2022 International Congress

    Perceive: A data extraction and analysis toolbox for brain signals from sensing enabled deep brain stimulators

    WJ. Neumann (Berlin, Germany)

    Objective: Develop an open source toolbox that facilitates data extraction, analysis, artifact correction and standardization for the DBS research community. Background: Novel sensing enabled implantable…
  • 2022 International Congress

    Parkinson’s disease symptom asymmetry at disease onset corresponds to low-beta power asymmetry in the subthalamic nucleus

    A. Buijink, F. Torrecillos, M. Stam, D. Piña-Fuentes, A. Pogosyan, C. Wiest, R. de Bie, P. Schuurman, G. Tinkhauser, H. Tan, M. Beudel (Amsterdam, Netherlands)

    Objective: Compare beta-power in the subthalamic nucleus (STN) between the most affected and least affected body side at disease onset. Background: Exaggerated beta activity (13–35…
  • 2022 International Congress

    At-home prolonged adaptive deep brain stimulation improves symptoms and reduces side effects in Parkinson’s disease

    C. Oehrn, S. Cernera, L. Hammer, M. Shcherbakova, A. Hahn, R. Gilron, C. Smyth, R. Wilt, S. Little, P. Starr (SAN FRANCISCO, USA)

    Objective: Objective: To assess the effect of at-home adaptive deep brain stimulation (aDBS) on symptoms and treatment-associated side-effects in one patient with Parkinson’s disease (PD),…
  • 2022 International Congress

    Personalization of deep brain stimulation using local field potentials to drive adaptive DBS: a case series

    H. Kamo, G. Oyama, T. Brionne, D. Kamiyama, A. Umemura, H. Iwamuro, A. Bovet, G. Spriano, A. Singer, P. Di Stefano, N. Hattori (Tokyo, Japan)

    Objective: To observe chronically recorded local field potentials (LFPs) in patients receiving Deep Brain Stimulation (DBS) for Parkinson’s Disease (PD) and using an adaptive DBS…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley